IP Library Granted Patent US 7,087,052
Granted Patent B2
US 7,087,052 · App. 10/676,619 · Granted Aug 8, 2006

Apparatus and method for treating venous reflux

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,087,052
App. No.
10/676,619
Granted
Aug 8, 2006
Kind
B2
Abstract

Disclosed is an ablation method and apparatus used to close veins for treatment of venous insufficiency disease. The apparatus includes a catheter proportioned for insertion into a vein, a pair of inflatable balloons spaced apart on the catheter body, and an ablation electrode array disposed between the balloons. According to the disclosed method, the catheter is introduced into the vein to be treated and the balloons are distended. Blood is flushed and aspirated from the site between the balloons. RF power is applied to the electrode array, causing scarring of the vessel walls and eventual sealing of the vein.

Claims (23)

1. A method of sealing a blood vessel, comprising the steps of:

providing a catheter including an elongate body, a pair of inflatable balloon members on the elongate body, and an electrode array on the elongate body between the balloons;

positioning the catheter within a blood vessel;

inflating the balloon members into contact with an interior wall of the blood vessel;

removing blood from the portion of the blood vessel extending between the inflated balloon members; and

energizing the electrode array to cause ablation of the interior wall of the blood vessel and, during the energizing step, applying suction in the region between the inflated balloon members to remove moisture released during ablation, said suction substantially preventing formation of a low-impedance liquid layer around the electrodes when ablation is carried out using the electrodes wherein in the applying step the suction at least partially collapses the vessel.

2. The method of claim 1 , wherein in the applying step the suction draws the interior wall into contact with the eletrode array.

3. The method of claim 1 , wherein the catheter elongate body includes a plurality of openings, and wherein the vacuum is applied through the openings.

4. The method of claim 1 , wherein suction is applied through the catheter during the applying step.

5. The method of claim 4 , wherein the catheter elongate body includes a plurality of openings, and wherein the suction is applied through the openings.

6. The method of claim 1 , wherein the removing step includes flushing the portion of the blood vessel extending between the balloon members with saline, and aspirating blood and saline from the said portion of the blood vessel.

7. The method of claim 1 , wherein the catheter elongate body includes a plurality of openings, and wherein the removing step includes applying a vacuum to the catheter to aspirate the blood out of the vessel through the openings.

8. The method of claim 1 , wherein the electrode array is a bipolar array.

9. The method of claim 1 , wherein the method further includes the steps of, prior to energizing the electrode array to cause ablation:

positioning the electrode array in contact with the interior wall of the blood vessel and measuring impedance of the tissue in contact with the electrode array; and

automatically selecting between a low impedance transformation circuit and a high impedance transformation circuit based on the impedance of the tissue in contact with the electrode array.

10. The method of claim 9 , wherein the step of measuring the impedance of the tissue in contact with the electrode array includes providing a low-power RF signal to the electrode array.

11. The method of claim 9 , wherein the step of selecting includes selecting the transformation circuit having an impedance closest to the measured impedance of the tissue in contact with the electrode array.

12. The method of claim 1 , wherein the energizing step causes flow of current into the tissue, and wherein the method further includes the step of causing automatic termination of current flow into the interior wall once a selected ablation depth has been approximately reached.

13. The method of claim 12 , wherein said termination occurs regardless of whether the electrode array continues to be energized.

14. The method of claim 1 , further comprising the step of compressing the blood vessel, causing opposed ablated regions of the interior wall to seal against one another.

15. The method of claim 1 , further the step of collapsing the catheter into a reduced diameter step and withdrawing the collapsed catheter from the vessel.

16. The method of claim 15 , wherein the collapsing step includes the step of applying a vacuum to a lumen in the catheter.

Assignments (8)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 25, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024944/0315 →
PATENT SECURITY AGREEMENT Recorded Jul 29, 2008
From: CYTYC SURGICAL PRODUCTS
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021311/0118 →
PATENT SECURITY AGREEMENT Recorded Oct 26, 2007
From: CYTYC SURGICAL PRODUCTS
To: GOLDMAN SACHS CREDIT PARTNERS L.P.
Reel/Frame 020018/0653 →
CHANGE OF NAME Recorded Nov 12, 2004
From: NOVACEPT
To: CYTYC SURGICAL PRODUCTS
Reel/Frame 015991/0624 →